Skip to content

ENDS IN 9 MONTHS

Consultation And Peer Review For The Division Of Risk Assessment And Prioritization

Food and Drug Administration · FDA OFFICE OF ACQ GRANT SVCS

Sign in to track this contract

CAN YOU BID THIS?

Open competition

  • Last award was competed and not reserved for a program, so any eligible firm can bid.

Sign in and add a company profile to get a call for your firm.

Pro adds how many offers it drew last time to this read.

Check before you spend bid hours

  • Dates and values are from USAspending as of Oct 20, 2026. Confirm the incumbent's end date with the contracting office or a Sources Sought before committing bid hours.
Incumbent
VERSAR, INC.
Other than small · UEI KTERFRZBVP66
Recompete expected (last option ends)
Jul 12, 2027
Current option period ends
Jul 12, 2027
Potential value
$694K ($694K obligated)
NAICS
541690 · Other Scientific And Technical Consulting Services
PSC
B529 · Special Studies/Analysis- Scientific Data
Set-aside
No set-aside
Vehicle
Standalone contract
Award type
Definitive Contract
Place of performance
MD
Solicitation ID
—
PIID
75F40126C00062

Last competition, subcontractors and incumbent

See how many offers this contract drew last time, who the incumbent subcontracts to, and the rest of the incumbent's expiring portfolio.

Unlock with Pro — $39 / mo

The buying office on SAM.gov

From notices this office (75F401) posted on SAM.gov in the last 12 months. Contacts are the duty points of contact published on those notices. All recompetes and contacts for this office →

Possibly already moving: 1 notice from this office may be this recompete. Open each one to confirm.

Pro emails you when a notice like these appears for a contract you track.

Recent notices from this office (1)

More expiring contracts from this office

Source: USAspending.gov prime award summary (FPDS), last modified Aug 3, 2026. Periods of performance change when options are exercised or the contract is modified; confirm on the source record before acting.